Statements of Stockholders' Equity (Deficit) - USD ($)	Common Stock	Additional Paid-In Capital	Deferred Stock-based Compensation	Accumulated Deficit	Total
Beginning balance, shares at Dec. 31, 2017	25,515,000
Beginning balance, value at Dec. 31, 2017	$ 2,552	$ 254,948		$ (279,487)	$ (21,987)
Common stock and warrants issued for cash, shares
Common stock and warrants issued for cash, value
Expense recognition of deferred stock-based compensation
Net loss				$ (18,020)	$ (18,020)
Ending balance, shares at Mar. 31, 2018	25,151,000
Ending balance, value at Mar. 31, 2018	$ 2,552	$ 254,948		$ (297,507)	$ (40,007)
Beginning balance, shares at Dec. 31, 2017	25,515,000
Beginning balance, value at Dec. 31, 2017	$ 2,552	$ 254,948		$ (279,487)	$ (21,987)
Net loss					$ (4,635,716)
Ending balance, shares at Dec. 31, 2018	36,303,800
Ending balance, value at Dec. 31, 2018	$ 3,630	$ 5,648,270	$ (829,167)	$ (4,915,203)	$ (92,470)
Beginning balance, shares at Mar. 31, 2018	25,151,000
Beginning balance, value at Mar. 31, 2018	$ 2,552	$ 254,948		$ (297,507)	$ (40,007)
Common stock and warrants issued for cash, shares
Common stock and warrants issued for cash, value
Expense recognition of deferred stock-based compensation
Net loss				$ (29,089)	$ (29,089)
Ending balance, shares at Jun. 30, 2018	25,515,000
Ending balance, value at Jun. 30, 2018	$ 2,552	$ 254,948		$ (326,596)	$ (69,096)
Common stock and warrants issued for cash, shares	63,800
Common stock and warrants issued for cash, value	$ 6	$ 31,894	$ (5,362,500)
Expense recognition of deferred stock-based compensation			1,958,334
Net loss				$ (1,988,589)	$ (1,988,589)
Ending balance, shares at Sep. 30, 2018	36,303,800
Ending balance, value at Sep. 30, 2018	$ 3,630	$ 5,648,270	$ (3,404,166)	$ (2,315,185)	$ (67,451)
Common stock and warrants issued for cash, shares
Common stock and warrants issued for cash, value
Expense recognition of deferred stock-based compensation			2,574,999		2,574,999
Net loss				$ (2,600,018)	$ (2,600,018)
Ending balance, shares at Dec. 31, 2018	36,303,800
Ending balance, value at Dec. 31, 2018	$ 3,630	$ 5,648,270	$ (829,167)	$ (4,915,203)	$ (92,470)
Common stock and warrants issued for cash, shares	200,000
Common stock and warrants issued for cash, value	$ 20	$ 99,980			$ 100,000
Expense recognition of deferred stock-based compensation			829,167		829,167
Net loss				$ (876,661)	$ (876,661)
Ending balance, shares at Mar. 31, 2019	36,503,800
Ending balance, value at Mar. 31, 2019	$ 3,650	$ 5,748,250		$ (5,791,864)	$ (39,964)
Beginning balance, shares at Dec. 31, 2018	36,303,800
Beginning balance, value at Dec. 31, 2018	$ 3,630	$ 5,648,270	$ (829,167)	$ (4,915,203)	$ (92,470)
Net loss					$ (947,319)
Ending balance, shares at Dec. 31, 2019	36,503,800
Ending balance, value at Dec. 31, 2019	$ 3,650	$ 5,748,250		$ (5,862,522)	$ (110,622)
Beginning balance, shares at Mar. 31, 2019	36,503,800
Beginning balance, value at Mar. 31, 2019	$ 3,650	$ 5,748,250		$ (5,791,864)	$ (39,964)
Common stock and warrants issued for cash, shares
Common stock and warrants issued for cash, value
Expense recognition of deferred stock-based compensation
Net loss				(30,875)	(30,875)
Ending balance, shares at Jun. 30, 2019	36,503,800
Ending balance, value at Jun. 30, 2019	$ 3,650	$ 5,748,250		$ (5,822,739)	$ (70,839)
Common stock and warrants issued for cash, shares
Common stock and warrants issued for cash, value
Expense recognition of deferred stock-based compensation
Net loss				$ (24,712)	$ (24,712)
Ending balance, shares at Sep. 30, 2019	36,503,800
Ending balance, value at Sep. 30, 2019	$ 3,650	$ 5,748,250		$ (5,862,522)	$ (110,622)
Common stock and warrants issued for cash, shares
Common stock and warrants issued for cash, value
Expense recognition of deferred stock-based compensation
Net loss
Ending balance, shares at Dec. 31, 2019	36,503,800
Ending balance, value at Dec. 31, 2019	$ 3,650	$ 5,748,250		$ (5,862,522)	$ (110,622)